StonvexLoading…
StonvexStonvexStonvexCore line items from TARS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $451.36M | $182.95M | $17.45M | $25.82M |
Operating Income | $-70.97M | $-120.57M | $-143.16M | $-62.71M |
Net Income | $-66.42M | $-115.55M | $-135.89M | $-62.09M |
EPS (Diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 |
Total Assets | $562.16M | $376.99M | $265.49M | $227.86M |
Total Liabilities | $218.73M | $152.46M | $68.50M | $34.96M |
Cash & Equivalents | $183.64M | $94.82M | $224.95M | $71.66M |
Free Cash Flow OCF − CapEx | $-22.31M | $-84.59M | $-119.00M | $-49.54M |
Shares Outstanding | 42.55M | 38.35M | 34.21M | 26.70M |